Recent publications published by researchers at the MRC WIMM.
Pathogenesis of fistulating Crohn's disease: a review.
Journal article
Chantelle McGregor CG. et al, (2022), Cell Mol Gastroenterol Hepatol
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response.
Journal article
Adams A. et al, (2022), Gut
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.
Journal article
Wellens J. et al, (2022), Gut, 71, 1919 - 1922
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.
Journal article
McGregor CG. et al, (2021), Gut, 70, 2398 - 2400
REAL WORLD EFFECTIVENESS OF USTEKINUMAB FOR REFRACTORY CROHN'S DISEASE: A REGIONAL EXPERIENCE
Conference paper
Mcgregor C. et al, (2021), GUT, 70, A108 - A108